Annual Accounts Payable
$3.21 M
+$168.30 K+5.53%
December 31, 2023
Summary
- As of February 7, 2025, VNRX annual accounts payable is $3.21 million, with the most recent change of +$168.30 thousand (+5.53%) on December 31, 2023.
- During the last 3 years, VNRX annual accounts payable has risen by +$1.67 million (+108.59%).
- VNRX annual accounts payable is now at all-time high.
Performance
VNRX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.49 M
-$863.20 K-25.78%
September 30, 2024
Summary
- As of February 7, 2025, VNRX quarterly accounts payable is $2.49 million, with the most recent change of -$863.20 thousand (-25.78%) on September 30, 2024.
- Over the past year, VNRX quarterly accounts payable has dropped by -$726.20 thousand (-22.61%).
- VNRX quarterly accounts payable is now -29.55% below its all-time high of $3.53 million, reached on March 31, 2024.
Performance
VNRX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
VNRX Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +5.5% | -22.6% |
3 y3 years | +108.6% | +110.3% |
5 y5 years | +297.8% | +192.7% |
VNRX Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +108.2% | -29.6% | +61.1% |
5 y | 5-year | at high | +411.9% | -29.6% | +296.2% |
alltime | all time | at high | +5675.7% | -29.6% | +4900.2% |
VolitionRx Limited Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $2.49 M(-25.8%) |
Jun 2024 | - | $3.35 M(-5.1%) |
Mar 2024 | - | $3.53 M(+9.9%) |
Dec 2023 | $3.21 M(+5.5%) | $3.21 M(+5.0%) |
Sep 2023 | - | $3.06 M(-12.4%) |
Jun 2023 | - | $3.49 M(+16.8%) |
Mar 2023 | - | $2.99 M(-1.8%) |
Dec 2022 | $3.04 M(+97.3%) | $3.04 M(+23.3%) |
Sep 2022 | - | $2.47 M(-5.2%) |
Jun 2022 | - | $2.60 M(+18.0%) |
Mar 2022 | - | $2.21 M(+43.0%) |
Dec 2021 | $1.54 M(+0.2%) | $1.54 M(+30.5%) |
Sep 2021 | - | $1.18 M(+9.1%) |
Jun 2021 | - | $1.08 M(-26.0%) |
Mar 2021 | - | $1.46 M(-4.9%) |
Dec 2020 | $1.54 M(+145.4%) | $1.54 M(+81.3%) |
Sep 2020 | - | $849.10 K(-40.0%) |
Jun 2020 | - | $1.41 M(-4.9%) |
Mar 2020 | - | $1.49 M(+137.2%) |
Dec 2019 | $627.30 K(-22.3%) | $627.30 K(+23.2%) |
Sep 2019 | - | $509.30 K(-61.4%) |
Jun 2019 | - | $1.32 M(+119.0%) |
Mar 2019 | - | $602.10 K(-25.4%) |
Dec 2018 | $807.20 K(+129.5%) | $807.20 K(-5.8%) |
Sep 2018 | - | $857.10 K(-25.8%) |
Jun 2018 | - | $1.16 M(+159.7%) |
Mar 2018 | - | $445.10 K(+26.6%) |
Dec 2017 | $351.70 K(+25.1%) | $351.70 K(-18.5%) |
Sep 2017 | - | $431.70 K(+16.7%) |
Jun 2017 | - | $369.80 K(-40.4%) |
Mar 2017 | - | $620.70 K(+120.7%) |
Dec 2016 | $281.20 K(-13.1%) | $281.20 K(-82.0%) |
Sep 2016 | - | $1.57 M(+35.4%) |
Jun 2016 | - | $1.16 M(+14.3%) |
Mar 2016 | - | $1.01 M(+212.8%) |
Dec 2015 | $323.50 K(-59.5%) | $323.50 K(-53.4%) |
Sep 2015 | - | $694.50 K(-2.5%) |
Jun 2015 | - | $712.10 K(+15.5%) |
Mar 2015 | - | $616.30 K(-22.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2014 | $797.90 K(+54.0%) | $797.90 K(+15.0%) |
Sep 2014 | - | $693.60 K(+57.4%) |
Jun 2014 | - | $440.70 K(-24.6%) |
Mar 2014 | - | $584.60 K(+12.8%) |
Dec 2013 | $518.10 K(+7.6%) | $518.10 K(+7.6%) |
Dec 2012 | $481.40 K(+765.8%) | $481.40 K(+69.1%) |
Sep 2012 | - | $284.70 K(+65.5%) |
Jun 2012 | - | $172.00 K(-23.7%) |
Mar 2012 | - | $225.30 K(+305.2%) |
Aug 2011 | - | $55.60 K(+2.4%) |
Aug 2011 | $55.60 K(-43.1%) | - |
May 2011 | - | $54.30 K(+2.5%) |
Feb 2011 | - | $53.00 K(+6.6%) |
Nov 2010 | - | $49.70 K(-49.1%) |
Aug 2010 | $97.70 K(+2.2%) | $97.70 K(-14.4%) |
May 2010 | - | $114.20 K(+1.3%) |
Feb 2010 | - | $112.70 K(+1.9%) |
Nov 2009 | - | $110.60 K(+15.7%) |
Aug 2009 | $95.60 K(-3.6%) | $95.60 K(-9.3%) |
May 2009 | - | $105.40 K(+3.9%) |
Feb 2009 | - | $101.40 K(+2.5%) |
Nov 2008 | - | $98.90 K(-0.3%) |
Aug 2008 | $99.20 K(+20.0%) | $99.20 K(+7.9%) |
May 2008 | - | $91.90 K(+4.4%) |
Feb 2008 | - | $88.00 K(+7.1%) |
Nov 2007 | - | $82.20 K(-0.6%) |
Aug 2007 | $82.70 K(+41.4%) | $82.70 K(+11.6%) |
May 2007 | - | $74.10 K(+3.8%) |
Feb 2007 | - | $71.40 K(+19.0%) |
Nov 2006 | - | $60.00 K(+2.6%) |
Aug 2006 | $58.50 K(-19.9%) | $58.50 K(+7.5%) |
May 2006 | - | $54.40 K(-4.4%) |
Feb 2006 | - | $56.90 K(+1.4%) |
Nov 2005 | - | $56.10 K(-23.2%) |
Aug 2005 | $73.00 K(+13.9%) | $73.00 K(-1.2%) |
May 2005 | - | $73.90 K(+4.2%) |
Feb 2005 | - | $70.90 K(+7.6%) |
Nov 2004 | - | $65.90 K |
Aug 2004 | $64.10 K | - |
FAQ
- What is VolitionRx Limited annual accounts payable?
- What is the all time high annual accounts payable for VolitionRx Limited?
- What is VolitionRx Limited annual accounts payable year-on-year change?
- What is VolitionRx Limited quarterly accounts payable?
- What is the all time high quarterly accounts payable for VolitionRx Limited?
- What is VolitionRx Limited quarterly accounts payable year-on-year change?
What is VolitionRx Limited annual accounts payable?
The current annual accounts payable of VNRX is $3.21 M
What is the all time high annual accounts payable for VolitionRx Limited?
VolitionRx Limited all-time high annual accounts payable is $3.21 M
What is VolitionRx Limited annual accounts payable year-on-year change?
Over the past year, VNRX annual accounts payable has changed by +$168.30 K (+5.53%)
What is VolitionRx Limited quarterly accounts payable?
The current quarterly accounts payable of VNRX is $2.49 M
What is the all time high quarterly accounts payable for VolitionRx Limited?
VolitionRx Limited all-time high quarterly accounts payable is $3.53 M
What is VolitionRx Limited quarterly accounts payable year-on-year change?
Over the past year, VNRX quarterly accounts payable has changed by -$726.20 K (-22.61%)